Total Funding
26
Total FundingGrant raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
128073
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product
Menzo Havenga: President & CEOPast Role: Crucell Holland BV, VP R&D
Christopher Yallop: Chief Operations and Scientific OfficerPast Role: Crucell Holland BV, Senior Director Protein R&D
About the Company
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost.
Our services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical
manufacturing and release.
Batavia Biosciences has successfully worked on viral and bacterial vaccines, recombinant proteins, antibodies and gene therapy products. Unique technologies such as STEP® protein expression technology and SCOUT® high throughput process technology accelerate timelines and reduce costs.
